Cargando…
MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
Introduction: Type 1 diabetes is an autoimmune condition resulting in insulin deficiency that requires daily insulin therapy and self-monitoring of blood glucose. Continuous glucose monitoring (CGM) systems allow for measurement of interstitial fluid glucose levels in a continuous fashion to identif...
Autores principales: | Owens, Lindsey L, Chalise, Sweta, Vyas, Neha, Gurnurkar, Shilpa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209684/ http://dx.doi.org/10.1210/jendso/bvaa046.649 |
Ejemplares similares
-
MON-153 Spurious High HbA1c: Do We Need to Review the Guidelines?
por: Eid, Hatem
Publicado: (2019) -
MON-LB025 An Artificially Low HbA1c as a Result of Dapsone Therapy
por: George, Robert, et al.
Publicado: (2019) -
MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects
por: Faustman, Denise, et al.
Publicado: (2019) -
SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019) -
Normalization of HbA1c Following an Ad-Libitum, Non-Ketogenic Low Carbohydrate Diet Along With Antidiabetic Agents
por: Torbay, Naji, et al.
Publicado: (2021)